The North America extreme lateral interbody fusion (XLIF) surgery market to be grow at a CAGR of 6.4% in the forecast period of 2022-2029. Extreme lateral interbody fusion surgery (XLIF) is a minimally invasive surgical treatment for treating back or leg discomfort. The most common cause of this discomfort is disc degeneration in the spine.
Bridgette Enterprises
Ild Innovative Living Design
Createsco
Hianime
Delta333
Ku88
Newchickenroad
Winbet
566
Jiniroy00